£6.7m awarded to find new ways to improve prevention, diagnosis and treatment of diseases
Barts Life Sciences - a partnership between Barts Health NHS Trust and Queen Mary University of London - has been awarded £6.7m by Barts Charity to research new ways to improve the prevention, diagnosis and treatment of a variety of diseases. The diseases that will be studied include COVID-19, cancer, heart disease and diabetes, which affect many in the east London population.
Barts Health is one of the largest NHS Trusts in the UK, caring for around 2.5 million patients in one of the most diverse and disadvantaged areas of the UK. This new multi-million-pound award will enable Barts Life Sciences to make better use of the information collected during the course of a person s NHS care - a currently untapped and underused source of data - which will be used for the benefit of patients and the wider population.
E-Mail
Barts Life Sciences is harnessing the untapped resource of patient data to discover new ways of improving patient care.
Specific health data collected from Barts Health NHS Trust patients over the course of their care will be securely analysed as part of new research that will directly benefit the 2.5 million patients the Trust cares for, as well as patients across the UK and beyond.
The £6.7m investment by Barts Charity marks a significant commitment to deliver advanced disease prevention and treatment to a population with some of the highest rates of illness and disadvantage in the UK, and to support east London s growing life and health data sciences sector.